Dnmt3A is required for genome wide de novo methylation and is essential for development.The synthetic peptide used to raise the antibody Cat. No. 200102 is selected from a sequence within the N-term region of human Dnmt3a. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.